E-Mail Updates

Click here to join
our Electronic Communications.

Investors & Media

Whats new.

Press releases

Press releases.

Immutep Completes $6.31 Million Share Purchase Plan; Raises Total of $13.16 Million

April 13th 2018
press releases

Operational Update

April 3rd 2018
press releases

Updated TACTI-mel Data presented at the Cambridge Healthtech Institute’s Immuno-Oncology Summit

March 22nd 2018
press releases

Investor updates

Investor updates.

Investor Update - December 2017

December 21st 2017
investor updates

Investor Update Edition 21

October 1st 2017
investor updates

Investor Update Edition 20

August 1st 2017
investor updates

Analyst reports

Analyst reports.

Merck collaboration opens new opportunities

March 29th 2018
analyst reports

IMP321 (LAG-3Ig) + Keytruda in Melanoma - Expansion Cohort Initiates Dosing

March 23rd 2018
analyst reports

Maxim - Raises Capital ($5.4M), Extends Runway as IMP321 Expands to a New Combination Study with Keytruda

March 15th 2018
analyst reports